ESC Premium Access

Peri-procedural treatment with high dose Rosuvastatin reduces soluble TNF receptor 1 in patients treated with primary percutaneous coronary intervention for ST elevation myocardial infarction

Congress Presentation

About the speaker

Doctor Noreen Butt

Stavanger University Hospital, Stavanger (Norway)
0 follower

16 more presentations in this session

Incidence of coronary heart disease in patients with familiar hypercholesterolemia compared to age- and sex- matched controls

Speaker: Doctor K. Svendsen (Oslo, NO)


Post-procedural cholesterol and inflammatory risk in acute myocardial infarction patients undergoing percutaneous coronary intervention

Speaker: Doctor R. CHEN (Beijing, CN)


The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in Poland: results of the TERCET Registry

Speaker: Associate Professor K. Dyrbus (Zabrze, PL)


Treatment patterns of lipid lowering therapy in patients with coronary artery disease above vs. below 75 years of age

Speaker: Doctor A. Mahabadi (Essen, DE)


Statin treatment in symptomatic patients with non-obstructive coronary artery disease reduces the risk of all-cause mortality

Speaker: Doctor C. Kissel (Zurich, CH)


Access the full session

Poster Session 1 - Acute coronary syndromes, coronary artery disease: treatment

Speakers: Doctor N. Butt, Doctor K. Svendsen, Doctor R. CHEN, Associate Professor K. Dyrbus, Doctor A. Mahabadi...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb